Zurich Cantonal Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $646K | Sell |
2,134
-4
| -0.2% | -$1.21K | ﹤0.01% | 1501 |
|
2025
Q1 | $708K | Sell |
2,138
-291
| -12% | -$96.4K | ﹤0.01% | 1383 |
|
2024
Q4 | $750K | Sell |
2,429
-13
| -0.5% | -$4.01K | ﹤0.01% | 1386 |
|
2024
Q3 | $518K | Sell |
2,442
-2
| -0.1% | -$424 | ﹤0.01% | 1540 |
|
2024
Q2 | $685K | Buy |
2,444
+387
| +19% | +$108K | ﹤0.01% | 1271 |
|
2024
Q1 | $549K | Buy |
2,057
+32
| +2% | +$8.55K | ﹤0.01% | 1407 |
|
2023
Q4 | $469K | Sell |
2,025
-14
| -0.7% | -$3.24K | ﹤0.01% | 1543 |
|
2023
Q3 | $298K | Buy |
2,039
+284
| +16% | +$41.5K | ﹤0.01% | 1708 |
|
2023
Q2 | $405K | Buy |
1,755
+122
| +7% | +$28.2K | ﹤0.01% | 1483 |
|
2023
Q1 | $396K | Buy |
1,633
+94
| +6% | +$22.8K | ﹤0.01% | 1431 |
|
2022
Q4 | $447K | Sell |
1,539
-54
| -3% | -$15.7K | ﹤0.01% | 1320 |
|
2022
Q3 | $104K | Hold |
1,593
| – | – | ﹤0.01% | 2189 |
|
2022
Q2 | $114K | Sell |
1,593
-33
| -2% | -$2.36K | ﹤0.01% | 2146 |
|
2022
Q1 | $160K | Buy |
1,626
+367
| +29% | +$36.1K | ﹤0.01% | 2034 |
|
2021
Q4 | $107K | Hold |
1,259
| – | – | ﹤0.01% | 2478 |
|
2021
Q3 | $100K | Hold |
1,259
| – | – | ﹤0.01% | 2333 |
|
2021
Q2 | $123K | Hold |
1,259
| – | – | ﹤0.01% | 2104 |
|
2021
Q1 | $147K | Hold |
1,259
| – | – | ﹤0.01% | 1958 |
|
2020
Q4 | $140K | Hold |
1,259
| – | – | ﹤0.01% | 2056 |
|
2020
Q3 | $149K | Hold |
1,259
| – | – | ﹤0.01% | 1795 |
|
2020
Q2 | $143K | Buy |
1,259
+757
| +151% | +$86K | ﹤0.01% | 1751 |
|
2020
Q1 | $34K | Hold |
502
| – | – | ﹤0.01% | 2128 |
|
2019
Q4 | $46K | Hold |
502
| – | – | ﹤0.01% | 2184 |
|
2019
Q3 | $43K | Hold |
502
| – | – | ﹤0.01% | 2140 |
|
2019
Q2 | $53K | Hold |
502
| – | – | ﹤0.01% | 2022 |
|
2019
Q1 | $63K | Hold |
502
| – | – | ﹤0.01% | 1865 |
|
2018
Q4 | $57K | Hold |
502
| – | – | ﹤0.01% | 1953 |
|
2018
Q3 | $107K | Hold |
502
| – | – | ﹤0.01% | 1670 |
|
2018
Q2 | $140K | Buy |
+502
| New | +$140K | ﹤0.01% | 1467 |
|